HF Sinclair (DINO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Enovix Corporation (ENVX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Casella (CWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

First Foundation (FFWM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

First Solar (FSLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Fortune Brands Innovations (FBIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chart Industries (GTLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Hub Group (HUBG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Alphabet Inc. delivered strong Q2 results, beating analyst estimates on both revenue and earnings per share. Revenue growth was broad-based, with Google Search showing robust 12% growth, easing concerns about AI-driven disruption. The company has a consistent track record of outperforming expectations, highlighting its operational strength and resilience.

CMG beats Q2 EPS estimates as new units and digital sales boost revenues. However, comps fall and outlook dims on weak demand.

Coherent Corp. (COHR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, COHR's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

The average of price targets set by Wall Street analysts indicates a potential upside of 91.1% in Alvotech (ALVO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.4% in Apogee Enterprises (APOG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

From a technical perspective, Preferred Bank (PFBC) is looking like an interesting pick, as it just reached a key level of support. PFBC's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

The mean of analysts' price targets for Crescent Energy (CRGY) points to a 67.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 303.5% in Day One Biopharmaceuticals (DAWN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 72.3% upside potential for Immunocore (IMCR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in On Holding (ONON). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.